BioMarin Pharmaceutical Inc. Common Stock.
NASDAQ-10085.79 0.65%
1M0.00% 1Y -0.00%  Analysts Review about BioMarin Pharmaceutical Inc. Common Stock
Market Consensus (11 Analysts)
Strong Buy
Price Target High $124.56
Spread: 46.13%
Price Target Average $119.77
Spread: 40.51%
Price Target Low $80.45
Spread: -5.62%
Technical Analyses Trend
Periods
Trend
Resistance
Support
Short Term
Neutral
91.96 (7.19%)
87.11 (1.54%)
Mid Term
Neutral
91.96 (7.19%)
84.07 (-2.01%)
Long Term
Neutral
97.35 (13.47%)
77.79 (-9.33%)
- 1W
- 1M
- 1Y
BioMarin Pharmaceutical Inc. Common Stock Articles
The Motley Fool
Prediction: These 6 AI Stocks Will Be Worth a Combined $20 Trillion by 2030
The top six AI stocks are currently worth a combined $9.5 trillion. They could reach $20 trillion or more by 2030 via different paths, with AI serving as a key tailwind.
Sentiment: Positive 2023-05-30
Proactive Investors
Sirius Real Estate completes early refinancing of debt
Sirius Real Estate said it completed the early refinancing of its €58.3mln debt facility with Deutsche Pfandbriefbank seven months before the due date. A statement from the owner and operator of business and industrial parks said the refinancing comprises a seven-year €58.3mln facility with a fixed interest rate of 4.25%.
Sentiment: Positive 2023-05-30
Zacks Investment Research
Loan Growth Supports M&T Bank (MTB) Despite Rising Costs
M&T Bank's (MTB) top line gets support from increasing loan and deposit balances. Continued rising expenses keep the bottom line under pressure, while worsening credit quality is worrisome.
Sentiment: Negative 2023-05-30
S&P Stocks Review about BioMarin Pharmaceutical Inc. Common Stock
SPS Rank 275th
SPS Rate 4.8
SPS Consensus (08 Analysts) Hold
Target Price 650.85 USD 658.66%
Potentials Excellent
Growth (Revenue) Extremely Poor
Finances NA
Profitability Very Poor
Earnings Quality Very Poor
P/E Ratio Excellent
Valuation Undervalued
Fair Value 428.93USD 399.98%
Source
Sentiment
Za
Positive
Se
Positive
Ma
Negative
In
Positive
In
Positive
In
Positive
Se
Positive
2023-05-29 Buy 8 May Buffett Dividend Dogs And Watch 7
Se
Positive
BioMarin Pharmaceutical Inc. Common Stock Overview 30 Nov 2020
Open 85.80
High 85.98
Low 84.86
1 Day Change (Last) 0.55
1 Day Change Percent (Last) 0.65%
Close 85.79
Previous Close 85.24
Volume 296,728
52 Week High 117.77
52 Week low 80.53
Gross Margin % 76.92%
Net Profit Margin % 6.75%
Total Shares Outstanding 187.70M
Market Capitalization 16.47B
BioMarin Pharmaceutical Inc. Common Stock Weight (BMRN) 0.04%
Dividends
Dividends Paid (Last Quarter) No Dividends
Dividends Paid (Last Fiscal Year)No Dividends
Dividends Per Share (Last Quarter) No Dividends
Dividends Yield (Last Fiscal Year) No Dividends
Dividends Per Share (Last Fiscal Year) No Dividends
Income Statement
Net Income (Last Fiscal Year) 141.56M
1 year Revenue2.10B
Last Quarter Revenue566.98M
4 months EPS revision 0.37